Journal article
Ligand-supported purification of the urotensin-II receptor
AT Du, D Onan, DT Dinh, MJ Lew, J Ziogas, MI Aguilar, LK Pattenden, WG Thomas
Molecular Pharmacology | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS | Published : 2010
Abstract
A crucial limitation for structural and biophysical analysis of G protein-coupled receptors (GPCRs) is the inherent challenge of purifying and stabilizing these receptors in an active (agonist-bound) conformation. Peptide ligands, such as the vasoactive, cyclic hormone urotensin-II (U-II), may provide new purification tools, via high affinity, pseudo-irreversible binding suitable for ligand-based affinity purification. We show that the U-II receptor (UT) is resistant to desensitization as a result of low phosphorylation and diminished endocytosis. UT also displays an unusual proclivity to remain active with vasoconstriction sustained despite extensive washout of the ligand. To exploit these ..
View full abstractGrants
Awarded by National Health and Medical Research Council of Australia
Funding Acknowledgements
This work was supported by National Health and Medical Research Council of Australia [Grants 268925, 251646, 334049] and by a Ph.D. scholarship from the Baker Heart Research Institute (to D.O.).